Skip to main content
Toggle navigation
Login
Search
Home
ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Abbasi, Saad
Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark
Sequential Safety Monitoring of Rofecoxib for Cardiovascular Adverse Effects
Location:Argyle 3
Saad Abbasi
Abtahi, Shahab
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
Impact of 2018 EU risk minimisation measures and revised pregnancy prevention programme on utilisation and prescribing trends of valproates
Location:Argyle 1
Shahab Abtahi
Ahlqvist, Viktor
Karolinska Institutet
Antiseizure Medication During Pregnancy and Offspring Neurodevelopmental Outcomes: A Study of Two Cohorts from the UK and Sweden
Location:Argyle 2
Viktor Ahlqvist
Ahuja, Tarry
Canadian Agency for Drugs and Technologies in Health
Introducing CoLab: The Evolution of US-Canada International Collaboration on Drug Safety and Effectiveness
Location:Argyle 3
Tarry Ahuja
Alcalde-Herraiz, Marta
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Sclerostin inhibition, cardiovascular biomarkers, risk factors, and clinical outcomes: a Mendelian randomisation analysis using UK Biobank data
Location:Argyle 3
Marta Alcalde-Herraiz
Alkabbani, Wajd
University of Waterloo
Insulin use in type 2 diabetes and the risk of dementia: A comparative population-based cohort study
Location:MR202
Wajd Alkabbani
Alsugeir, Dana
University college london
Risk of Osteoporotic Fractures in Menopausal Women with Common Mental Health Problems Using SSRI/SNRI antidepressants: Cohort Study
Location:Argyle 2
Dana Alsugeir
Anand, Priyanka
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital
Comparison of EHR data-completeness in patients with different types of medical insurance coverage in the United States
Location:Argyle 1
Priyanka Anand
A dynamic prognostic model for identifying vulnerable COVID-19 patients at high risk of rapid deterioration
Location:Argyle 3
Priyanka Anand
Andersen, Kathleen
Pfizer
Defining Post-COVID Conditions Using Changes in Symptomatology in Electronic Health Record Data from the United States
Location:Argyle 3
Kathleen Andersen
Vaccines: Boosting Confidence
Location:MR201
Kathleen Andersen
Ansah, Nana
Navrongo Health Research Centre
Reporting Adverse Events Following Immunization in Ghana - Health Care Workers Experiences
Location:Argyle 1
Nana Ansah
Ataher, Quazi
CSL Behring, King of Prussia, PA, USA
Leveraging Real-World Insights to Inform Long-term Follow-up for Cell and Gene Therapies: Opportunities for Pharmacoepidemiologists
Location:MR201
Quazi Ataher
Aung-Thin, Pamela
Health Canada
Town Hall: Global Regulatory Forum on Real-World Evidence; Sponsored by ISPE's RWE Collaborative SIG
Location:Ballroom
Pamela Aung-Thin
Ayele, Henok Tadesse
Merck & Co., Inc.
Intermediate /Advanced Topics in Vaccine Safety and Effectiveness
Location:MR202
Henok Tadesse Ayele
